597 related articles for article (PubMed ID: 18597625)
1. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
[TBL] [Abstract][Full Text] [Related]
2. The epithelial Ca2+ channel TRPV5 is essential for proper osteoclastic bone resorption.
van der Eerden BC; Hoenderop JG; de Vries TJ; Schoenmaker T; Buurman CJ; Uitterlinden AG; Pols HA; Bindels RJ; van Leeuwen JP
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17507-12. PubMed ID: 16291808
[TBL] [Abstract][Full Text] [Related]
3. Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice.
Renkema KY; Nijenhuis T; van der Eerden BC; van der Kemp AW; Weinans H; van Leeuwen JP; Bindels RJ; Hoenderop JG
J Am Soc Nephrol; 2005 Nov; 16(11):3188-95. PubMed ID: 16148038
[TBL] [Abstract][Full Text] [Related]
4. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
David P; Nguyen H; Barbier A; Baron R
J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
[TBL] [Abstract][Full Text] [Related]
5. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
Niikura K; Takeshita N; Takano M
J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
[TBL] [Abstract][Full Text] [Related]
6. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6.
van Abel M; Huybers S; Hoenderop JG; van der Kemp AW; van Leeuwen JP; Bindels RJ
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1177-83. PubMed ID: 16705151
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin-stimulated renal Ca2+ reabsorption occurs independently of TRPV5.
Hsu YJ; Dimke H; Hoenderop JG; Bindels RJ
Nephrol Dial Transplant; 2010 May; 25(5):1428-35. PubMed ID: 19965988
[TBL] [Abstract][Full Text] [Related]
10. Ion transporters involved in acidification of the resorption lacuna in osteoclasts.
Henriksen K; Sørensen MG; Jensen VK; Dziegiel MH; Nosjean O; Karsdal MA
Calcif Tissue Int; 2008 Sep; 83(3):230-42. PubMed ID: 18787885
[TBL] [Abstract][Full Text] [Related]
11. S 12911-2 inhibits osteoclastic bone resorption in vitro.
Takahashi N; Sasaki T; Tsouderos Y; Suda T
J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
[TBL] [Abstract][Full Text] [Related]
12. Membrane-bound carbonic anhydrases in osteoclasts.
Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
[TBL] [Abstract][Full Text] [Related]
13. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
Masuyama R; Vriens J; Voets T; Karashima Y; Owsianik G; Vennekens R; Lieben L; Torrekens S; Moermans K; Vanden Bosch A; Bouillon R; Nilius B; Carmeliet G
Cell Metab; 2008 Sep; 8(3):257-65. PubMed ID: 18762026
[TBL] [Abstract][Full Text] [Related]
14. Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel.
Combs CE; Fuller K; Kumar H; Albert AP; Pirianov G; McCormick J; Locke IC; Chambers TJ; Lawrence KM
J Endocrinol; 2012 Feb; 212(2):187-97. PubMed ID: 22083217
[TBL] [Abstract][Full Text] [Related]
15. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins.
Nijenhuis T; Renkema KY; Hoenderop JG; Bindels RJ
J Am Soc Nephrol; 2006 Mar; 17(3):617-26. PubMed ID: 16421227
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
Altundal H; Sayrak H; Yurtsever E; Göker K
J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
[TBL] [Abstract][Full Text] [Related]
17. Phenotype of a calbindin-D9k gene knockout is compensated for by the induction of other calcium transporter genes in a mouse model.
Lee GS; Lee KY; Choi KC; Ryu YH; Paik SG; Oh GT; Jeung EB
J Bone Miner Res; 2007 Dec; 22(12):1968-78. PubMed ID: 17696760
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
19. Ion channels and transporters in osteoclasts.
Supanchart C; Kornak U
Arch Biochem Biophys; 2008 May; 473(2):161-5. PubMed ID: 18406337
[TBL] [Abstract][Full Text] [Related]
20. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
Lees RL; Heersche JN
J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
